Skip to content

Thermo Fisher Scientific TMO Additional Paid-In Capital

Additional Paid-In Capital at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$19.77B-1.0%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$1.86B+9.8%
GLW
CorningGLW
Danaher logo
DanaherDHR
WAT
Waters CorporationWAT
Mettler-Toledo International, Inc. logo
Mettler-Toledo International, Inc.MTD

Other financials

Income statement

See full
Revenue$11.0B+6.2%
Operating income$1.9B+8.6%
Net income$1.7B+9.6%
EPS (diluted)$4.43+11.3%

Balance sheet

See full
Cash & equivalents$3.3B-21.4%
Total debt$43.2B+16.6%
Total equity$51.9B+5.1%
Total assets$113.28B+14.4%

Cash flow

See full
Operating cash flow$1.2B+64.9%
CapEx$376.0M+3.9%
Free cash flow$816.0M+126%

Valuation

See full
Market cap$172.66B-2.7%
Enterprise value$212.54B+0.9%
P/E25.2×-2.0×
P/S-0.8×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp

Returns & leverage

See full
Return on equity13.5%-0.2pp
Debt / equity0.8×+0.1×
Current ratio1.5×-0.2×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Thermo Fisher Scientific's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Thermo Fisher Scientific's additional paid-in capital?
Thermo Fisher Scientific (TMO) reported additional paid-in capital of $18.71B in Q1 2026.
How has Thermo Fisher Scientific's additional paid-in capital changed year-over-year?
Thermo Fisher Scientific's additional paid-in capital increased by 3.3% year-over-year, from $18.11B to $18.71B.
What is the long-term trend for Thermo Fisher Scientific's additional paid-in capital?
Over 5 years (2020 to 2025), Thermo Fisher Scientific's additional paid-in capital has grown at a 3.6% compound annual growth rate (CAGR), from $15.58B to $18.56B.